Penumbra, Inc. (NYSE:PEN) CFO Sridhar Kosaraju sold 6,026 shares of the firm’s stock in a transaction that occurred on Tuesday, November 28th. The stock was sold at an average price of $103.83, for a total transaction of $625,679.58. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Sridhar Kosaraju also recently made the following trade(s):

  • On Wednesday, November 22nd, Sridhar Kosaraju sold 2,600 shares of Penumbra stock. The shares were sold at an average price of $105.99, for a total transaction of $275,574.00.
  • On Friday, November 24th, Sridhar Kosaraju sold 4,818 shares of Penumbra stock. The shares were sold at an average price of $105.10, for a total transaction of $506,371.80.
  • On Friday, November 17th, Sridhar Kosaraju sold 4,290 shares of Penumbra stock. The shares were sold at an average price of $103.52, for a total transaction of $444,100.80.
  • On Monday, November 20th, Sridhar Kosaraju sold 21,956 shares of Penumbra stock. The shares were sold at an average price of $105.27, for a total transaction of $2,311,308.12.
  • On Wednesday, November 15th, Sridhar Kosaraju sold 10,900 shares of Penumbra stock. The shares were sold at an average price of $105.89, for a total transaction of $1,154,201.00.

Penumbra, Inc. (NYSE:PEN) traded up $0.60 during midday trading on Friday, reaching $105.90. The company’s stock had a trading volume of 153,080 shares, compared to its average volume of 206,801. Penumbra, Inc. has a 12-month low of $57.85 and a 12-month high of $116.35.

Penumbra (NYSE:PEN) last issued its earnings results on Tuesday, November 7th. The company reported $0.01 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.07. The company had revenue of $83.90 million for the quarter, compared to the consensus estimate of $79.17 million. Penumbra had a negative return on equity of 1.95% and a negative net margin of 2.19%. The firm’s quarterly revenue was up 24.9% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.04) EPS. equities analysts expect that Penumbra, Inc. will post -0.15 earnings per share for the current year.

Several equities analysts have recently issued reports on PEN shares. BidaskClub downgraded shares of Penumbra from a “buy” rating to a “hold” rating in a report on Friday, August 18th. Canaccord Genuity reiterated a “buy” rating and issued a $100.00 price target (up from $94.00) on shares of Penumbra in a research report on Wednesday, August 9th. BMO Capital Markets boosted their price objective on Penumbra from $96.00 to $117.00 and gave the stock an “outperform” rating in a report on Wednesday, November 8th. Finally, Zacks Investment Research downgraded Penumbra from a “hold” rating to a “sell” rating in a report on Saturday, August 12th.

Several institutional investors and hedge funds have recently modified their holdings of the company. FMR LLC increased its holdings in shares of Penumbra by 1.2% in the 2nd quarter. FMR LLC now owns 5,042,974 shares of the company’s stock valued at $442,521,000 after purchasing an additional 57,801 shares during the period. Vanguard Group Inc. increased its holdings in shares of Penumbra by 2.3% in the 2nd quarter. Vanguard Group Inc. now owns 2,165,995 shares of the company’s stock valued at $190,066,000 after purchasing an additional 47,768 shares during the period. BlackRock Inc. increased its holdings in shares of Penumbra by 4.7% in the 2nd quarter. BlackRock Inc. now owns 1,815,299 shares of the company’s stock valued at $159,294,000 after purchasing an additional 81,981 shares during the period. Lord Abbett & CO. LLC increased its holdings in shares of Penumbra by 5.1% in the 2nd quarter. Lord Abbett & CO. LLC now owns 1,093,621 shares of the company’s stock valued at $95,965,000 after purchasing an additional 53,109 shares during the period. Finally, State Street Corp grew its stake in shares of Penumbra by 13.2% in the 2nd quarter. State Street Corp now owns 579,911 shares of the company’s stock valued at $50,887,000 after buying an additional 67,441 shares in the last quarter. Institutional investors own 71.70% of the company’s stock.

WARNING: This article was first posted by Daily Political and is owned by of Daily Political. If you are reading this article on another publication, it was stolen and reposted in violation of US & international copyright and trademark laws. The original version of this article can be accessed at https://www.dailypolitical.com/2017/12/02/sridhar-kosaraju-sells-6026-shares-of-penumbra-inc-pen-stock.html.

Penumbra Company Profile

Penumbra, Inc is a healthcare company focused on interventional therapies. The Company designs, develops, manufactures and markets medical devices. It has a portfolio of products that addresses medical conditions and clinical needs across two markets, neuro and peripheral vascular. The conditions that its products address include ischemic stroke, hemorrhagic stroke and various peripheral vascular conditions that can be treated through thrombectomy and embolization procedures.

Insider Buying and Selling by Quarter for Penumbra (NYSE:PEN)

Receive News & Ratings for Penumbra Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Penumbra Inc. and related companies with MarketBeat.com's FREE daily email newsletter.